First Alzheimer's disease risk assessment blood test for consumers hits market

Quest Diagnostics announced Monday that it launched the first direct-to-consumer blood test to help people assess their risk of developing Alzheimer's disease.

Related Keywords

Lisa Ricciardi ,Michael Racke ,Quest Diagnostics ,Cognition Therapeutics President ,Detect Test ,Detect Amyloid Beta ,Quest Diagnostic ,